MERRIMACK PHARMACEUTICALS INC Quarterly Earnings Per Share, Basic in USD/shares from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Merrimack Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2011 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending March 31, 2024 was 13.9 USD/shares.
  • Merrimack Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending March 31, 2024 was 13.9 USD/shares.
  • Merrimack Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -0.08 USD/shares, a 27.3% increase from 2022.
  • Merrimack Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -0.11 USD/shares, a 38.9% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.90 $13.90 +$14.00 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $0 $0 +$0.02 +66.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $0 $0 +$0.01 +33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $0 $0 +$0.01 +25% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $0 $0 $0 -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $0 +$0.01 +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $0 +$0.02 +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2012 -$2 -$1 -58.5% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-15
Q1 2011 -$1 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.